🔗 Share this article

An underground economy for unlicensed weight-loss medications is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors promote the substance there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering products of uncertain source.

Several professionals stated the popularity for retatrutide could be linked to the rising price of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.

Platform Reaction and Content Removal

Based on TikTok, the platform has removed problematic content and banned related keywords and query recommendations. The organization stated it was committed to keeping the service safe and investing in strengthening compliance measures.

Digital Trading Operations

Investigations also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, filled with photos of weight loss, glowing testimonials and step-by-step guides for preparing or administering at home.

Within moments of entering one community, a seller posted contact information, where most purchases occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or past usage.

Product Information and Pricing

Within these communities, posts display dark colored packages with Royal Mail labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20mg. When asked how much time a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service said it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these digital products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her team has previously seen individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company investigational substance not yet approved … may subject users to potentially significant medical dangers”.